Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol

INTRODUCTION: Haemodialysis (HD) is the cornerstone treatment for patients with end-stage renal disease (ESRD). However, highly protein bound or large molecular weight uremic toxins such as phenolic and indolic compounds and homocysteine, which are associated with adverse outcomes such as cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wei, Jiang, Geng-Ru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067402/
https://www.ncbi.nlm.nih.gov/pubmed/30056391
http://dx.doi.org/10.1136/bmjopen-2018-022169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067402/
https://www.ncbi.nlm.nih.gov/pubmed/30056391
http://dx.doi.org/10.1136/bmjopen-2018-022169

Ejemplares similares